Joseph O. Moore

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Chad A. LaGrange, Geoffrey E. Wile, R. Advani, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.

J. Radich, B. D. Smith, Hema M Sundar, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.

Susan O'Brien, Jason Gotlib, Moshe Talpaz, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.